pI: 9.2852 |
Length (AA): 858 |
MW (Da): 102029 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
416 | 711 | 1q79 (A) | 34 | 358 | 18.00 | 0 | 1 | 0.21 | -1.01 |
421 | 767 | 1fa0 (A) | 19 | 412 | 18.00 | 0 | 1 | 0.5 | -0.75 |
7 | 155 | 4tql (A) | 45 | 195 | 13.00 | 0.11 | 0.01 | 0.38416 | -1.06 |
409 | 704 | 3nyb (A) | 161 | 461 | 29.00 | 0.000000000055 | 1 | 0.757288 | -0.44 |
441 | 633 | 4zrl (A) | 561 | 796 | 30.00 | 0.0044 | 0.95 | 0.365842 | 0.57 |
7 | 155 | 4tql (A) | 45 | 195 | 13.00 | 0.088 | 0.01 | 0.38376 | -1.05 |
12 | 172 | 2ap3 (A) | 29 | 194 | 17.00 | 0.78 | 0.06 | 0.423746 | -0.96 |
409 | 704 | 3nyb (A) | 161 | 461 | 29.00 | 0.0000000000055 | 1 | 0.766888 | -0.54 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, sporozoite, early ring, late ring. | Otto TD PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, early schizont, early trophozoite, late trophozoite, Oocyst, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | merozoite, late schizont, Sporozoite, Female Gametocyte, Male Gametocyte. | PlasmoDB Zanghi G Lasonder E |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_127416)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G53770 | nucleotidyltransferase family protein |
Babesia bovis | BBOV_III006620 | hypothetical protein |
Brugia malayi | Bm1_48580 | PAP/25A associated domain containing protein |
Candida albicans | CaO19.8059 | Mitotic chromosome condensation |
Candida albicans | CaO19.429 | Mitotic chromosome condensation |
Caenorhabditis elegans | CELE_ZK858.1 | Protein GLD-4 |
Cryptosporidium hominis | Chro.70404 | hypothetical protein |
Cryptosporidium parvum | cgd7_3630 | TRF4/5 nucletotidyl transferase |
Dictyostelium discoideum | DDB_G0295737 | PAP/25A-associated domain-containing protein |
Drosophila melanogaster | Dmel_CG11265 | CG11265 gene product from transcript CG11265-RE |
Echinococcus granulosus | EgrG_000623000 | nucleotidyltransferase |
Entamoeba histolytica | EHI_087330 | topoisomerase, putative |
Entamoeba histolytica | EHI_003910 | hypothetical protein, conserved |
Entamoeba histolytica | EHI_073170 | topoisomerase, putative |
Echinococcus multilocularis | EmuJ_000623000 | nucleotidyltransferase |
Giardia lamblia | GL50803_16285 | Topoisomerase I-related protein |
Homo sapiens | ENSG00000121274 | PAP associated domain containing 5 |
Homo sapiens | ENSG00000112941 | PAP associated domain containing 7 |
Leishmania braziliensis | LbrM.07.0770 | topoisomerase-related function protein-like protein |
Leishmania donovani | LdBPK_070780.1 | topoisomerase-related function protein-like protein |
Leishmania infantum | LinJ.07.0780 | topoisomerase-related function protein-like protein |
Leishmania major | LmjF.07.0700 | topoisomerase-related function protein-like protein |
Leishmania mexicana | LmxM.07.0700 | topoisomerase-related function protein-like protein |
Loa Loa (eye worm) | LOAG_05671 | PAP/25A associated domain-containing protein |
Mus musculus | ENSMUSG00000034575 | PAP associated domain containing 7 |
Mus musculus | ENSMUSG00000036779 | PAP associated domain containing 5 |
Neospora caninum | NCLIV_043710 | hypothetical protein, conserved |
Oryza sativa | 4325901 | Os01g0672700 |
Plasmodium berghei | PBANKA_1347200 | nucleotidyltransferase, putative |
Plasmodium falciparum | PF3D7_1332400 | nucleotidyltransferase, putative |
Plasmodium knowlesi | PKNH_1268200 | nucleotidyltransferase, putative |
Plasmodium vivax | PVX_082550 | hypothetical protein, conserved |
Plasmodium yoelii | PY05727 | topoisomerase-related function protein |
Saccharomyces cerevisiae | YOL115W | non-canonical poly(A) polymerase PAP2 |
Saccharomyces cerevisiae | YNL299W | non-canonical poly(A) polymerase TRF5 |
Schistosoma japonicum | Sjp_0133600 | ko:K03514 DNA polymerase sigma subunit, putative |
Schistosoma japonicum | Sjp_0309770 | expressed protein |
Schistosoma mansoni | Smp_145600 | hypothetical protein |
Schmidtea mediterranea | mk4.002515.01 | |
Schmidtea mediterranea | mk4.005006.01 | |
Schmidtea mediterranea | mk4.005006.00 | |
Trypanosoma brucei gambiense | Tbg972.8.650 | DNA polymerase sigma, putative |
Trypanosoma brucei | Tb927.8.1090 | NPAPL |
Trypanosoma congolense | TcIL3000_8_690 | DNA polymerase sigma, putative |
Trypanosoma cruzi | TcCLB.508543.10 | DNA polymerase sigma, putative |
Trypanosoma cruzi | TcCLB.506401.100 | DNA polymerase sigma, putative |
Toxoplasma gondii | TGME49_210440 | polynucleotide adenylyltransferase |
Theileria parva | TP02_0312 | hypothetical protein |
Trichomonas vaginalis | TVAG_080950 | Poly(A) RNA polymerase protein, putative |
Trichomonas vaginalis | TVAG_314620 | trf5, putative |
Trichomonas vaginalis | TVAG_490130 | PAP-associated domain-containing protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1090 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1090 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1090 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.1090 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_ZK858.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_ZK858.1 | Caenorhabditis elegans | slow growth | wormbase |
CELE_ZK858.1 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_1347200 | Plasmodium berghei | Slow | plasmo |
TGME49_210440 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.